Article
Neutralizing antibody and T-cell spike targeted responses following receipt of a monovalent Omicron JN.1-adapted mRNA COVID-19 vaccine in immunosuppressed and healthy individuals
2025-05-06
Abstract excerpt
We evaluated homologous neutralizing antibody (NtAb) and T-cell responses after receipt of a JN.1-adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n=15), end-stage chronic kidney disease (CKD) patients (n=17), and allogeneic hematopoietic stem cell transplant recipients (allo-HCT) (n=13). Most participants (42/45) were SARS-CoV-2-experienced at the time of immunological testing. JN.1-sp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 04182c66-0947-5feb-a478-9c8eef77093b
- DOI
- 10.22541/au.174653646.66883385/v1
